Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
David Margolis MD, PhD

David J. Margolis MD, PhD

Chair, Committee on Appointments and Promotions; Assistant Dean of Faculty Affairs; Vice Chair of Faculty Affairs, Department of Dermatology; Gerald S. Lazarus Professor of Dermatology and Professor of Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania

David Margolis is the Gerald S. Lazarus Professor of Dermatology at the University of Pennsylvania Perelman School of Medicine. He is the Vice Chair for Faculty Affairs for the Department of Dermatology. He also has an appointment as a Professor of Epidemiology in the Department of Biostatistics, Epidemiology, and Informatics. Dr. Margolis's research work has focused on using pharmacoepidemiologic tools to study the epidemiology and treatment of chronic wounds, atopic dermatitis, acne, and other dermatological illnesses. He has been the Principal Investigator of several NIH, industry, and foundation grants, focused on developing a predictions model for treating venous leg ulcers, on evaluating the association of genetic and immunogenetic variation on the persistence of and risk for atopic dermatitis, as well as investigator-initiated trials using gene therapy in phase I studies to treat venous leg ulcers and diabetic foot ulcers, and recently a randomized non inferiority trial on oral therapy for acne. Finally, he has a long history of using administrative and medical record databases to improve our knowledge of dermatologic illnesses.

Disclosures

Dr. Margolis has consulting relationships with Pfizer, Janssen, and Incyte. He has research funding received by the trustees of the University of Pennsylvania from NIH, Pfizer, and Bausch (Valeant).

Recent Contributions to PracticeUpdate:

  1. Reducing the Risk of Prolonged Antimicrobial Resistance in Skin